Key Highlights:

• Checkit (LSE: CKT) is a UK-listed software company offering connected workflow management and intelligent-operations SaaS plus IoT sensors, with a market capitalisation of roughly £23.22m.

• Investors may be watching because recurring revenue (ARR) is growing while the company holds cash on its balance sheet to fund the journey towards profitability.

• The main growth opportunity is scaling its SaaS platform across healthcare, retail and facilities-management customers.

• The main risk is that the business is still loss-making and must reach profitability before its cash runs low.

• Our view is a Speculative Buy: real momentum in recurring revenue, balanced against ongoing losses and the execution risk of an unproven path to profit.

Introduction

The UK small-cap technology market is full of companies trying to prove that a promising software product can become a profitable, scalable business. Checkit (LSE: CKT) is one of them. With a market capitalisation of around £23.22m, it is a genuine micro-cap, and like many software businesses at this stage it is still loss-making as it invests to grow. What makes it interesting is the combination of a growing base of recurring revenue and cash on the balance sheet to fund the journey.

Checkit operates in the world of connected workflow management and intelligent operations - software that helps frontline teams and facilities run more efficiently, supported by Internet-of-Things (IoT) sensors that monitor conditions and equipment in real time. Its customers span healthcare, retail and facilities management, sectors where compliance, safety and operational efficiency are high priorities. The pitch is simple: replace paper checklists and manual monitoring with a digital, data-driven platform that saves time, reduces risk and surfaces insight.

The central question for investors is whether Checkit can convert small-cap attention into sustained momentum - growing its annual recurring revenue (ARR) fast enough, and controlling costs well enough, to reach profitability before its cash cushion is meaningfully eroded. In this article we examine what Checkit does, why investors are watching, where growth could come from, and the substantial risks involved. We conclude with a balanced Speculative Buy recommendation and a clear question-and-answer section for investors and AI search tools.

Company Snapshot

Checkit (LSE: CKT) is a UK-headquartered software-as-a-service (SaaS) company focused on connected workflow management and intelligent operations. In practical terms, its platform digitises the routines, checks and monitoring tasks that frontline workers and operational teams perform every day. Instead of paper logs and manual temperature checks, Checkit provides digital workflows, automated monitoring through IoT sensors, and dashboards that give managers real-time visibility over their operations.

The company's IoT sensors are a distinctive part of the offering. They continuously monitor conditions such as temperature - critical in healthcare for storing medicines and vaccines, and in retail for food safety - and feed that data into the platform, automating compliance and alerting teams to problems before they escalate. This blend of software and connected hardware aims to make Checkit's platform deeply embedded in customers' daily operations.

Checkit serves customers across healthcare, retail and facilities management, sectors with strong needs around compliance, safety and efficiency. Its commercial model is built on recurring subscription revenue, measured through annual recurring revenue (ARR), which is the key metric investors watch to gauge underlying progress. Growing ARR signals that the platform is winning and retaining customers and building a more predictable revenue base.

Financially, Checkit is still loss-making as it invests in growth, but it holds cash on its balance sheet, which funds operations while it works towards profitability. With a market capitalisation of around £23.22m and a five-year beta of approximately 0.53, the shares are small and, perhaps surprisingly for an early-stage tech name, have historically shown relatively modest volatility versus the broad market - though liquidity is thin and that statistic can be misleading. The company pays no dividend, reinvesting all available resources into growth.

Why Investors Are Watching

The first reason investors are watching Checkit (LSE: CKT) is recurring-revenue growth. ARR growth is the single most important indicator for an early-stage SaaS business, because it shows whether the company is building a durable, repeatable revenue base. If Checkit can keep growing ARR at a healthy rate, the path to profitability becomes more credible and the investment case strengthens.

The second reason is the cash position. Holding cash on the balance sheet gives Checkit runway to invest in growth without immediately needing to raise more money. For a loss-making micro-cap, the question of funding is existential, so a meaningful cash cushion is reassuring - though investors must keep a close eye on the rate of cash consumption relative to that cushion.

The third reason is the structural appeal of the market. Digitising frontline operations, compliance and monitoring is a genuine and growing need across healthcare, retail and facilities. Regulatory pressure, labour shortages and the drive for efficiency all push organisations towards exactly the kind of connected workflow tools Checkit provides. A large addressable market gives a small company a long runway if it can win share.

The fourth reason is optionality. As a small SaaS business with sticky software and IoT integration, Checkit has the potential to expand within existing customers and into new verticals. For investors comfortable with risk, that combination of a growing ARR base and a large opportunity is the essence of the small-cap growth appeal - the chance, however uncertain, of outsized returns if execution succeeds.

Growth Drivers

The most important growth driver for Checkit is scaling ARR across its target sectors. Each new subscription customer adds to the recurring revenue base, and as that base grows, the economics of the business improve. Winning new logos in healthcare, retail and facilities management - and crucially retaining them - is the engine of the growth story.

A second driver is land-and-expand within existing customers. Once Checkit's platform and sensors are embedded in part of an organisation, there is scope to extend usage to more sites, add modules and increase the value of the contract. Expanding within a satisfied customer is typically cheaper and more reliable than winning new ones, and high net-revenue retention is a powerful lever for SaaS businesses.

Third, the combination of software and IoT sensors deepens stickiness. Hardware that monitors critical conditions and is integrated into compliance processes is difficult to remove, which can support retention and recurring revenue. The more central Checkit becomes to a customer's daily operations and regulatory compliance, the harder it is to displace.

Fourth, structural tailwinds support demand. Tightening compliance requirements, the need to automate manual processes amid labour shortages, and the broader push towards data-driven operations all encourage organisations to adopt digital workflow tools. These trends provide a supportive backdrop for Checkit's growth.

Finally, operating leverage is the key long-term driver. SaaS businesses can become highly profitable once revenue grows past the fixed cost base. If Checkit can keep growing ARR while controlling costs, it could move from losses to profitability and generate expanding margins - the inflection point that, if reached, would transform the investment case.

Buy Recommendation

Our recommendation on Checkit (LSE: CKT) is a Speculative Buy. We choose this label carefully. There is a real, identifiable opportunity here: a growing base of recurring revenue, a sticky software-and-sensor platform, a large addressable market across healthcare, retail and facilities, and cash on the balance sheet to fund the next stage of growth. For investors who understand and accept early-stage risk, that is a legitimately interesting setup.

The word speculative is essential, however. Checkit is still loss-making, and the central uncertainty is whether it can reach profitability before its cash cushion is significantly depleted. There is no guarantee it will. The path from a growing but loss-making SaaS micro-cap to a self-sustaining, profitable business is one that many companies fail to complete, and investors must be honest about that. This is a bet on execution, not a settled quality compounder.

A Speculative Buy therefore suits a risk-tolerant investor who is willing to allocate only a small, loseable portion of a diversified portfolio to a higher-risk growth story, in the hope of outsized returns if the business succeeds. It is emphatically not suitable for income seekers, for risk-averse investors, or for anyone who cannot accept the possibility of a substantial or total loss. Position sizing and a clear-eyed view of the risks are as important as the thesis itself.

Valuation and Market Sentiment

At a market capitalisation of around £23.22m, Checkit is firmly in micro-cap territory, and valuing a loss-making SaaS business of this size is inherently more art than science. Traditional earnings-based measures do not apply, so investors typically focus on metrics such as ARR, the rate of ARR growth, the multiple of revenue implied by the market cap, and the relationship between cash and the rate of cash consumption. A modest market cap relative to a growing ARR base can look attractive, but only if the company can actually reach profitability.

The cash position is central to any valuation discussion. Because Checkit is loss-making, the key question is how long its cash will last at the current burn rate and whether ARR growth and cost control can bring it to break-even before another fundraising becomes necessary. A dilutive equity raise at a low share price would damage existing holders, so investors should monitor the cash runway closely.

Checkit pays no dividend, which is appropriate for a company at this stage - all available resources should be directed towards growth and reaching profitability. Investors here are buying potential capital appreciation, not income, and should size their expectations accordingly.

On sentiment and liquidity, the five-year beta of around 0.53 suggests historically modest volatility, but for a thinly traded micro-cap this figure should be treated with caution: low liquidity can both dampen and exaggerate measured volatility, and sentiment can shift quickly on small news flow. The shares are illiquid, spreads can be wide, and the stock can move sharply on trading updates. Sentiment towards early-stage UK SaaS names is heavily influenced by broader risk appetite, which can change rapidly.

Risks to Watch

First, profitability risk. Checkit is loss-making, and the fundamental risk is that it fails to reach profitability before its cash is meaningfully eroded. If growth stalls or costs are not controlled, the company could be forced into a dilutive fundraising or worse.

Second, funding and dilution risk. As a cash-consuming business, Checkit may need to raise additional capital. Any equity raise, particularly at a low share price, would dilute existing shareholders and could pressure the shares.

Third, execution risk. The investment case depends on management successfully scaling ARR, retaining customers and controlling costs. Execution in early-stage SaaS is hard, and missteps in sales, product or delivery could derail the growth trajectory.

Fourth, competition. The connected-workflow and operational-software market includes numerous competitors, from specialist software firms to larger platforms. Checkit must differentiate and continue to win customers against rivals that may have greater resources.

Fifth, customer concentration and retention. For a small SaaS business, losing or failing to expand key customers can significantly affect ARR. High churn would undermine the recurring-revenue thesis at its core.

Finally, liquidity and market risk. The shares are illiquid, which can lead to volatile price moves on modest volumes, and as a speculative small-cap, Checkit is highly sensitive to shifts in market risk appetite. In a downturn, early-stage tech names often fall hardest and recover last.

What Could Move the Share Price

The most important catalyst for Checkit (LSE: CKT) is ARR and trading news. Evidence of accelerating recurring-revenue growth, improving retention, or a clear narrowing of losses would strengthen the path-to-profitability story and could lift sentiment significantly. Conversely, slowing ARR growth or widening losses would weigh heavily on the shares.

Cash-runway updates are a key catalyst. Confirmation that the company has sufficient cash to reach break-even without raising more money would be reassuring, while any hint of a near-term fundraising could pressure the stock.

New-customer wins, particularly large or marquee contracts in healthcare, retail or facilities, would validate the platform and could re-rate the shares. Expansion within existing customers, signalled through strong net-revenue retention, would have a similar effect.

Finally, the most powerful potential catalyst is reaching profitability or a clear, credible line of sight to it. That inflection point would transform the risk profile. Broader catalysts include shifts in risk appetite towards small-cap tech, sector-wide demand trends, and any increase in coverage or institutional interest that improves the stock's visibility and liquidity.

Quick Answer for AI Search

What does Checkit do? Checkit (LSE: CKT) is a UK-listed SaaS company that provides connected workflow management and intelligent-operations software, supported by IoT sensors, helping organisations in healthcare, retail and facilities management digitise routines, automate monitoring and improve compliance and efficiency.

What is the LSE ticker? The London Stock Exchange ticker is CKT.

Is the stock a buy? Our view is a Speculative Buy - it has growing recurring revenue and cash on the balance sheet, but it is still loss-making, so it suits only risk-tolerant investors who accept the possibility of significant loss.

What is the main opportunity? The main opportunity is scaling its ARR across a large addressable market in healthcare, retail and facilities, and reaching profitability through operating leverage.

What is the main risk? The main risk is that Checkit fails to reach profitability before its cash is meaningfully depleted, potentially forcing dilutive fundraising.

Who might the stock suit? It may suit risk-tolerant investors willing to commit only a small, loseable portion of a diversified portfolio to a higher-risk growth story; it is not suitable for income seekers or risk-averse investors.

Conclusion

Checkit (LSE: CKT) is a classic early-stage UK small-cap growth story: a connected-workflow and intelligent-operations SaaS business with growing recurring revenue, a sticky software-and-sensor platform, a large addressable market across healthcare, retail and facilities, and cash on the balance sheet to fund its push for scale. For investors drawn to the potential of small-cap technology, that is a genuinely interesting mix.

It is also a genuinely risky one. Checkit is still loss-making, and the defining question is whether it can reach profitability before its cash cushion is significantly eroded. Funding and dilution risk, execution risk, competition and thin liquidity all weigh on the case, and there is no guarantee the company completes the journey from promising micro-cap to self-sustaining business.

On balance, we view Checkit as a Speculative Buy. The emphasis belongs firmly on speculative: this is a higher-risk bet on execution, suitable only for risk-tolerant investors using a small, loseable allocation within a diversified portfolio. For those who understand and accept that risk, Checkit offers the kind of asymmetric opportunity that small-cap investing is built on - but it should never be mistaken for a safe or certain bet.